Prenatal screening for chromosome abnormalities in a region with no access to termination of pregnancy
- 9 April 2009
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 29 (7) , 659-663
Abstract
Objective To analyze the different variables that affect couples' decision-making about prenatal screening of chromosome abnormalities in a population with limited access to prenatal diagnosis and no legal termination of pregnancy (TOP). Methods From February through August 2004, 79 couples who requested for prenatal screening at centers from Argentina and Uruguay participated in a study. A cross-sectional survey was administered to assess attitudes toward prenatal screening, the decision-making process, and knowledge and attitudes toward TOP. Results Mean maternal age was 32.8 ± 0.4 years. Among the couples, 88.61% knew that TOP due to fetal anomalies is not legal in their countries. When asked about the possibility of TOP in case of a serious fetal anomaly, 53% would contemplate this option. Conclusion Prenatal screening is a common practice worldwide. However, unlike most developed countries, our region has a limited access to prenatal diagnosis and no legal TOP. Those couples who stated that ‘reassurance about fetal well-being’ was the most important reason to perform prenatal screening had more positive attitudes toward TOP than those who considered this screening important ‘to be better prepared to receive the baby’. Our findings can be used to inform and revise current health-care policies. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 24 references indexed in Scilit:
- Women's opinions on the offer and use of nuchal translucency screening for Down syndromePrenatal Diagnosis, 2006
- First-Trimester or Second-Trimester Screening, or Both, for Down's SyndromeNew England Journal of Medicine, 2005
- Applying decision analysis to facilitate informed decision making about prenatal diagnosis for Down syndrome: a randomised controlled trialPrenatal Diagnosis, 2004
- First-Trimester Sonographic Screening for Down Syndrome*1Obstetrics & Gynecology, 2003
- Combined second-trimester biochemical and ultrasound screening for Down syndromeObstetrics & Gynecology, 2002
- Association between first trimester absence of fetal nasal bone on ultrasound and Down syndromePrenatal Diagnosis, 2002
- Increased fetal nuchal translucency at 11–14 weeksPrenatal Diagnosis, 2002
- Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.BMJ, 1992
- Anxiety Concerning Fetal Malformations in Pregnant Women Exposed or Not Exposed to an Antenatal Serum Alpha–Fetoprotein Screening ProgramGynecologic and Obstetric Investigation, 1984
- WOMEN'S ATTITUDES TO SCREENING FOR NEURAL TUBE DEFECTSBJOG: An International Journal of Obstetrics & Gynaecology, 1980